Cosentyx is a biologic drug used to treat several conditions, including psoriasis, psoriatic arthritis, and ankylosing spondylitis. The drug works by targeting a specific protein that causes inflammation in the body. According to Drug Patent Watch [1], Cosentyx was approved by the FDA in 2015 and is manufactured by Novartis Pharmaceuticals Corporation.

Regarding the COVID-19 pandemic, Cosentyx's official website [2] states that there is currently no data to suggest that taking Cosentyx increases the risk of contracting COVID-19. However, people taking Cosentyx should follow the guidelines provided by their healthcare provider and take extra precautions to avoid exposure to the virus.

Medical News Today [3] reports that Cosentyx has been shown to be effective in treating psoriasis, psoriatic arthritis, and ankylosing spondylitis. The drug has also been shown to improve patients' quality of life and reduce symptoms such as pain, swelling, and stiffness. However, like all medications, Cosentyx may cause side effects, including infections, allergic reactions, and injection site reactions.

In conclusion, whether to recommend Cosentyx to others depends on individual circumstances and should be discussed with a healthcare provider. While Cosentyx has been shown to be effective in treating certain conditions, it may not be appropriate for everyone. Patients taking Cosentyx should follow their healthcare provider's instructions and take extra precautions during the COVID-19 pandemic.

Sources:
[1] https://www.drugpatentwatch.com/p/biologics/tradename/COSENTYX
[2] https://www.cosentyx.com/covid19
[3] https://www.medicalnewstoday.com/articles/326632